Novelon Lite 0.02 mg+3 mg (Tablet)

(24 active+4 inert) tablet: ৳ 425.00

Medicine Details

Indications

  • Oral contraceptive
  • Treatment of moderate acne vulgaris
  • Treatment of premenstrual dysphoric disorder (PMDD)

Pharmacology

  • Contains Ethinylestradiol and Drospirenone
  • Inhibits ovulation by suppressing gonadotropin release
  • Changes in cervical mucus to increase difficulty of sperm penetration
  • Changes in endometrium to reduce likelihood of implantation
  • Drospirenone has antimineralocorticoid activity

Dosage

  • Tablets must be taken daily at about the same time
  • Start with the first pink tablet and continue daily for 24 days
  • Withdrawal bleeding usually starts on days 2-3 after starting the white tablets

Administration

  • Management of Missed Tablets
  • Delaying a period
  • Advice in case of Vomiting

Interaction

  • Interactions between ethinylestradiol and other drugs may affect concentrations
  • Certain antibiotics and substances may reduce efficacy of oral contraceptives

Contraindications

  • Known or suspected pregnancy
  • Heart disease, clotting of blood in the vein
  • Liver disease, jaundice
  • High blood pressure, migraine
  • Venous or arterial thromboembolic events
  • Migraine with focal neurological symptoms
  • Pancreatitis and severe hypertriglyceridaemia
  • Severe renal insufficiency or acute renal failure
  • Presence or history of liver tumors
  • Undiagnosed vaginal bleeding
  • Hypersensitivity to any of the components

Side Effects

  • Dizziness
  • Headache
  • Breast pain
  • Nausea
  • Unscheduled uterine bleeding
  • Migraine
  • Changes in eyesight or speech
  • Unusual pain or swelling in legs
  • Chest pains
  • Rash
  • Yellow skin
  • Rise in blood pressure

Pregnancy & Lactation

  • Contraindicated during pregnancy
  • Pregnancy must be excluded before starting
  • Use during lactation may influence breast milk
  • Small amounts of the contraceptive steroids and/or their metabolites may be excreted with the milk

Precautions & Warnings

  • Benefits should be weighed against possible risks for each individual woman
  • Physician should decide on use if aggravation or exacerbation of conditions occur
  • Not indicated after menopause

Use in Special Populations

  • Indicated after menarche
  • No need for dosage adjustment

Overdose Effects

  • May include nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue
  • Withdrawal bleeding may occur in females
  • No specific antidote

Therapeutic Class

  • Oral Contraceptive preparations

Storage Conditions

  • Do not store above 30°C
  • Keep away from light and out of the reach of children

Related Brands